Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML Remains on track to initiate Phase 3 pivotal trial of ELVN-001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback